Who is BlueRock?

BlueRock Therapeutics, a wholly-owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company using its unique cell+gene platform to direct cellular differentiation and genetically engineer cells to create a new generation of cellular medicines that address large patient populations suffering from neurological, cardiovascular, and immunology diseases.

The convergence of cell biology and genetic engineering is creating fundamental new ways to impact disease. Founded in 2016 to capitalize on these technological breakthroughs, we are advancing our novel cell+gene platform to develop, manufacture, and deliver an entirely new generation of authentic and engineered cell therapies across three therapeutic areas: neurology, cardiology, and immunology.

What Are We Doing?

Our foundational science harnesses the ability to create and then direct the differentiation of universal pluripotent stem cells into authentic, functional cells that can be used as allogeneic cellular therapies to treat a broad array of diseases. We can also further engineer these cells, enabling them to produce enzymes, antibodies, and other proteins for additional therapeutic benefit.

We are passionate about delivering on the promise of cellular and gene therapy, shaping the future of cellular medicine, and delivering new therapies to millions of patients with treatment options.

We are seeking individuals who are collaborative, thrive in a fun and dynamic culture, and are steadfast in the commitment to advance cutting-edge cellular therapies to impact patients’ lives.

It continues to be an exciting time for BlueRock Therapeutics as the company advances cutting edge cellular therapies to positively impact patients’ lives across multiple disease areas.

The Director of Imaging and Biomarkers, Translational Medicine, will be expected to take on a highly visible role with internal and external stakeholders through the management of the imaging protocols and biomarkers leveraged in BlueRock’s clinical development programs. The Director of Imaging and Biomarkers will leverage their expertise in CNS, ophthalmic and inflammation imaging to advance the company’s development pipeline by working closely with program leads and other subject matter experts. The position will be based in Cambridge, Massachusetts.

Responsibilities:

As a critical member of the Translational Medicine team, the Director of Imaging and Biomarkers will leverage their expertise in CNS, ophthalmic and inflammation to:
Develop translational strategies designed to support clinical development plans, the regulatory path, and product commercialization.
Partner with Research to discover and characterize novel biomarker endpoints in preclinical studies.
Develop biomarker methods and analytically validate biomarkers for clinical use.
Implement clinical biomarkers and ensure biomarker-driven decision-making across all phases of drug development.
Deliver subject matter expertise with respect to clinically advanced techniques in MRI, PET, SPECT, HRCT and other modalities as needed.
Oversee CRO vendor/partners ensuring that they optimally execute clinical and preclinical imaging projects in the US, Europe and potentially Asia.
Provide support for the Business Development organizations as needed on diligence efforts.

Minimum Requirements:

Advanced degree required, Ph.D. preferred, in an imaging related discipline (Neuroscience preferred) with at least 6 years of industry experience and recognition as a contributor in the field of preclinical and clinical imaging science.
Must have direct experience managing imaging protocols in the conduct of clinical trials (endpoints, inter-site harmonization, imaging core lab oversight, etc.).
Specific experience with imaging endpoints for early-stage clinical development in CNS, ophthalmic and inflammatory diseases is desired.
PET imaging experience required.
Remote or hybrid can be arranged.

#LI-AL1

BlueRock Therapeutics Company Culture Highlights

Winner of Boston Business Journal’s Best Places to Work (Mid-size Company) 2023

Winner of Comparably’s Award for Best Company for Diversity 2022

Winner of Comparably’s Award for Best Company for Women 2022

Winner of Comparably’s Award for Best CEO 2022

BlueRock Therapeutics is ranked in the top 5% of companies for Overall Culture on Comparably.

Engineering Department is ranked in the top 5% of companies for Overall Culture on Comparably.

Check us out on Comparably: https://www.comparably.com/companies/bluerock-therapeutics

Equal Opportunity Workplace: At BlueRock, we welcome and support differences and diversity and we are proud to be an equal opportunity workplace. Please let us know if you require disability-related accommodation or other grounds protected by human rights legislation during the recruitment process so that we can work with you to meet your needs.

Responsibilities:

Minimum Requirements:

6 month growth

1 year growth

2 year growth

Simplify's Take

What believers are saying

What critics are saying

What makes BlueRock Therapeutics unique